Lupin Receives Tentative Nod For Anti-Seizure Drug; Stock Edges Higher
Tuesday, August 17, 2021
Comment
"The company (Lupin) has received tentative approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Brivaracetam Tablets," Lupin said
from NDTV Profit - Latest https://ift.tt/3swFvhq
from NDTV Profit - Latest https://ift.tt/3swFvhq
0 Response to "Lupin Receives Tentative Nod For Anti-Seizure Drug; Stock Edges Higher"
Post a Comment